Anker, a well-known consumer electronics company, recently unveiled its first over-the-counter (OTC) hearing aids at IFA 2026, a major global electronics trade show. OTC hearing aids are devices that consumers can purchase without a prescription, offering a more accessible and often less expensive alternative to traditional hearing aids that require a doctor’s recommendation. This announcement comes at a pivotal time for the OTC hearing aid market, which has seen significant shifts in recent months. LXE Hearing, the parent company of two prominent OTC hearing aid brands—Eargo and Lexie Hearing—announced earlier this year that it would cease its U.S. operations and exit the OTC hearing aid market. This decision marked a notable development, as Eargo and Lexie Hearing had been key players in the growing OTC space, offering products that appealed to a wide range of consumers seeking affordable hearing solutions. Anker’s new hearing aids use a receiver-in-canal (RIC) design, which is a common style in modern hearing aids. This design features a small, discreet device that sits behind the ear, with a thin wire connecting to a receiver that fits inside the ear canal. This setup allows for better sound quality and comfort compared to older models. The devices are powered by Anker’s Thus chip, a piece of technology that was first introduced in April and used in the company’s Soundcore Liberty 5 Pro earbuds. The Thus chip is known for its ability to isolate voice signals effectively, reducing background noise and enhancing clarity. With Anker entering the OTC hearing aid market, the landscape for hearing assistance devices is evolving. As more companies explore this space, consumers may benefit from increased competition, innovation, and a broader range of options for addressing hearing loss without the need for a prescription.